Don’t Forget
Hydrogen
Molecular hydrogen leaders in MedTech & HealthTech
WHO WE ARE & OUR TEAM
We are, a global leader in providing safe, reliable, and effective hydrogen solutions.
H2 Global Group & H2 Medical Technologies. Team includes medical doctors, scientists, and pharmacists, deep know-how and quality.
Tailored Solutions for Market Segments
H2 Global Group focuses on the professional and wholesale market, bringing high-quality molecular hydrogen products to the healthcare, wellness, sports, and cosmetics industries. We collaborate with medical professionals, therapists, pharmacies, and other partners, offering not only innovative technologies but also expert support and long-term cooperation opportunities.
H2 VIBE is dedicated to individuals looking to incorporate the benefits of molecular hydrogen into their daily routines. We provide a comprehensive range of products as well as services —from dietary supplements and hydrogen water to advanced molecular hydrogen generators—designed with a strong emphasis on quality, efficacy, and ease of use.
Our unique solution
Clinical studies
There are thousands of clinical studies exploring the effects of Molecular Hydrogen®. We have gathered the most relevant ones and organized them into categories. The result is a clear and accessible library that confirms the potential of this promising molecule.
Prof. Shigeo Ohta, Ph.D.
Director of Science and Research
Co-Founder
PharmDr. Milan Krajíček, Ph.D.
Director of R&D and Production
Co-Founder
MedTech & HealthTech
Sectors where we apply our solutions.
HEALTHCARE
We are at the forefront of research into the use of molecular hydrogen in medicine. We focus on developing innovative therapeutic approaches based on the unique properties of this more than promising molecule.
Global Presence
Neurology
and Psychiatry
Stomatology
and Dental Care
Wellness
and Spa
Rehabilitation
and Sports
Dermal Medicine and Skincare
VETERINARY
Molecular hydrogen generators, approved for veterinary use, bring innovative care to veterinary clinics and breeding facilities. Thanks to their anti-inflammatory and regenerative effects, they speed up recovery after physical exertion, relieve muscle pain and support the overall vitality of animals.
Molecular Hydrogen and Alzheimer’s disease
Molecular hydrogen is emerging as a promising breakthrough in the Alzheimer’s disease sphere. As a selective antioxidant and anti-inflammatory agent, it helps protect brain cells by reducing oxidative stress, improving mitochondrial function, and supporting neurogenesis.
We have developed a patented approach that deals with the use of molecular hydrogen for Alzheimer’s prevention and treatment, offering new hope for patients and their families. With its strong safety profile and long-term benefits, molecular hydrogen represents an innovative and natural way to support cognitive function and overall well-being.
News
Interview on Czech Radio at 6:20 a.m. with neurologist Prof. MUDr. David Školoudík, Ph.D., FESO, FEAN, and David Maršálek, CEO and Founder of H2 Global Group, discussing molecular hydrogen and the first clinical study of its kind in the Czech Republic.
A unique experiment is being prepared in Ostrava. For the first time in the Czech Republic, physicians will study the effect of hydrogen on the risk and early symptoms of Alzheimer’s dementia. Inhaling molecular hydrogen may help delay memory problems and improve...
“Staying Forever Young”: H2 Global Group Brings a Hydrogen Standard to the Longevity Sector
Prague, 3 December 2025 (PROTEXT) – The longevity market is experiencing a global boom. More and more people are becoming aware of the vast possibilities of today’s modern world, and the desire to reach an advanced age while staying free of major health issues and in...
H2 Global Group – Press Conference at ČTK
Molecular Hydrogen and Dementia Prevention: Czech Research Heads into Its First Clinical Study Today, on 12 November 2025, a press conference of H2 Medical Technologies, part of the H2 Global Group, was held at the ČTK Press Centre, where we announced a major...









